J&J to buy heart pump maker Abiomed in $16.6B deal

By CNBC
| November 01, 2022

Johnson & Johnson said on Tuesday it would buy heart pump maker Abiomed in a $16.6 billion deal, its biggest in nearly six years, as the conglomerate seeks to boost its cardiovascular business.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...